These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16037287)

  • 1. Significance of proximal tubular metabolism of advanced glycation end products in kidney diseases.
    Saito A; Takeda T; Sato K; Hama H; Tanuma A; Kaseda R; Suzuki Y; Gejyo F
    Ann N Y Acad Sci; 2005 Jun; 1043():637-43. PubMed ID: 16037287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of megalin, a proximal tubular endocytic receptor, in the pathogenesis of diabetic and metabolic syndrome-related nephropathies: protein metabolic overload hypothesis.
    Saito A; Takeda T; Hama H; Oyama Y; Hosaka K; Tanuma A; Kaseda R; Ueno M; Nishi S; Ogasawara S; Gondaira F; Suzuki Y; Gejyo F
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S26-31. PubMed ID: 16174284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin.
    Ozdemir AM; Hopfer U; Rosca MV; Fan XJ; Monnier VM; Weiss MF
    Am J Nephrol; 2008; 28(1):14-24. PubMed ID: 17890854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies.
    Daroux M; Prévost G; Maillard-Lefebvre H; Gaxatte C; D'Agati VD; Schmidt AM; Boulanger E
    Diabetes Metab; 2010 Feb; 36(1):1-10. PubMed ID: 19932633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processing advanced glycation end product-modified albumin by the renal proximal tubule and the early pathogenesis of diabetic nephropathy.
    Ozdemir AM; Hopfer U; Erhard P; Monnier VM; Weiss MF
    Ann N Y Acad Sci; 2005 Jun; 1043():625-36. PubMed ID: 16037286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-prepared advanced glycation end-products and the modulating potential of their low-molecular weight degradation products in IRPTC-A rat proximal-tubular derived kidney epithelial cell line.
    Deuther-Conrad W; Franke S; Henle T; Sommer M; Stein G
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL187-96. PubMed ID: 11936867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.
    Meerwaldt R; Zeebregts CJ; Navis G; Hillebrands JL; Lefrandt JD; Smit AJ
    Am J Kidney Dis; 2009 Jan; 53(1):138-50. PubMed ID: 19036487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Matsui T; Inoue H; Takeuchi M
    Med Hypotheses; 2007; 69(3):666-8. PubMed ID: 17331665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation endproducts (AGEs) as uremic toxins.
    Schwenger V; Zeier M; Henle T; Ritz E
    Nahrung; 2001 Jun; 45(3):172-6. PubMed ID: 11455783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
    Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure.
    Yamada K; Miyahara Y; Hamaguchi K; Nakayama M; Nakano H; Nozaki O; Miura Y; Suzuki S; Tuchida H; Mimura N
    Clin Nephrol; 1994 Dec; 42(6):354-61. PubMed ID: 7882598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.
    Maeda S; Matsui T; Takeuchi M; Yamagishi S
    Diabetes Metab Res Rev; 2013 Jul; 29(5):406-12. PubMed ID: 23508966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products overload might explain intracellular cobalamin deficiency in renal dysfunction, diabetes and aging.
    Obeid R; Shannan B; Herrmann W
    Med Hypotheses; 2011 Nov; 77(5):884-8. PubMed ID: 21880434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats.
    Boor P; Celec P; Behuliak M; Grancic P; Kebis A; Kukan M; Pronayová N; Liptaj T; Ostendorf T; Sebeková K
    Metabolism; 2009 Nov; 58(11):1669-77. PubMed ID: 19608208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megalin-mediated endocytosis of cystatin C in proximal tubule cells.
    Kaseda R; Iino N; Hosojima M; Takeda T; Hosaka K; Kobayashi A; Yamamoto K; Suzuki A; Kasai A; Suzuki Y; Gejyo F; Saito A
    Biochem Biophys Res Commun; 2007 Jun; 357(4):1130-4. PubMed ID: 17462596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products and the kidney.
    Bohlender JM; Franke S; Stein G; Wolf G
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F645-59. PubMed ID: 16159899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy.
    Zhou H; Tan KC; Shiu SW; Wong Y
    Nephrol Dial Transplant; 2008 Mar; 23(3):927-33. PubMed ID: 18065800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal N(epsilon)-carboxymethyllysine deposition after kidney transplantation.
    Baumann M; Caron M; Schmaderer C; Schulte C; Viklicky O; von Weyhern CW; Lutz J; Heemann U
    Transplantation; 2008 Jul; 86(2):330-5. PubMed ID: 18645498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
    Friedman EA
    Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megalin binds and mediates cellular internalization of folate binding protein.
    Birn H; Zhai X; Holm J; Hansen SI; Jacobsen C; Christensen EI; Moestrup SK
    FEBS J; 2005 Sep; 272(17):4423-30. PubMed ID: 16128811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.